Ledger.Open graph →
SEC Form D · filed July 8, 2022

Jaguar Health, Inc

Offering
$10.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jonathan B. Siegel · San Francisco, CADirectorLisa Conte · San Francisco, CAExec · DirectorJohn Micek Iii · San Francisco, CADirectorJames Bochnowski · San Francisco, CADirectorAnula B. Jayasuriya · San Francisco, CADirectorDavid Jeffrey · London, United KingdomDirectorCarol Lizak · San Francisco, CAExecSteven King · San Francisco, CAExecJonathan Wolin · San Francisco, CAExecEgen Atkinson · New York, NYExecElyse E. Stock · Chapel Hill, NCDirectorPeter J. Schreck · Boston, MADirectorGilles J. De Vignemont · Summit, NJExecMorton Wendell · New York, NYDirectorBlake Dube · Pittsburgh, PAExec · DirectorMichael Kramarz · New York, NYExecMichael Mccormick · New York, NYDirectorCraig E. Walters · Ft. Worth., TXExec · DirectorBrian T. Stevens · Farmington Hills, MIExecMichelle D. Spreitzer · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecPeter Henn · Farmington Hills, MIDirectorZiqiang Tang · Berkeley, CADirectorAnton Quiroz · Plano, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗